{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:20:58Z","timestamp":1795072858630,"version":"4.10.2"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871709"],"award-info":[{"award-number":["81871709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971994"],"award-info":[{"award-number":["81971994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172335"],"award-info":[{"award-number":["82172335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91846103"],"award-info":[{"award-number":["91846103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clim.2022.109153","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:58:55Z","timestamp":1666015135000},"page":"109153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus"],"prefix":"10.1016","volume":"245","author":[{"given":"Xingyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clim.2022.109153_bb0005","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic lupus erythematosus (SLE) therapy: the old and the new","volume":"7","author":"Basta","year":"2020","journal-title":"Rheumatol. Therapy"},{"key":"10.1016\/j.clim.2022.109153_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","article-title":"mTOR: role in cancer, metastasis and drug resistance","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0025","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR Signalling pathway in human Cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"46","key":"10.1016\/j.clim.2022.109153_bb0030","first-page":"173","article-title":"mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?","volume":"9","author":"Fernandez","year":"2010","journal-title":"Discov. Med."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0035","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2022.109153_bb0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.18632\/aging.100925","article-title":"Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","article-title":"Treg cells in autoimmunity: from identification to Treg-based therapies","volume":"41","author":"G\u00f6schl","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0065","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.clim.2022.109153_bb0070","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","article-title":"mTOR substrate phosphorylation in growth control","volume":"185","author":"Battaglioni","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121584","article-title":"Targeting mTOR and metabolism in cancer: lessons and innovations","volume":"8","author":"Magaway","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.clim.2022.109153_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102373","article-title":"The immunobiology of mTOR in autoimmunity","volume":"110","author":"Suto","year":"2020","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0085","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.it.2018.04.006","article-title":"Metabolism as a target for modulation in autoimmune diseases","volume":"39","author":"Huang","year":"2018","journal-title":"Trends Immunol."},{"issue":"19","key":"10.1016\/j.clim.2022.109153_bb0095","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/1873-3468.12711","article-title":"mTORC1 and mTORC2 as regulators of cell metabolism in immunity","volume":"591","author":"Linke","year":"2017","journal-title":"FEBS Lett."},{"issue":"21","key":"10.1016\/j.clim.2022.109153_bb0100","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222570","article-title":"Nutrient regulation of mTORC1 at a glance","volume":"132","author":"Condon","year":"2019","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tcb.2014.03.003","article-title":"Regulation of mTORC1 by amino acids","volume":"24","author":"Bar-Peled","year":"2014","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.clim.2022.109153_bb0110","doi-asserted-by":"crossref","first-page":"20753","DOI":"10.3390\/ijms151120753","article-title":"Current models of mammalian target of rapamycin complex 1 (mTORC1) activation by growth factors and amino acids","volume":"15","author":"Zheng","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2022.109153_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","article-title":"mTORC1 signaling and the metabolic control of cell growth","volume":"45","author":"Ben-Sahra","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"8","key":"10.1016\/j.clim.2022.109153_bb0120","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/ijc.29707","article-title":"Rheb signaling and tumorigenesis: mTORC1 and new horizons","volume":"138","author":"Armijo","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","article-title":"Regulation of mTORC1 by PI3K signaling","volume":"25","author":"Dibble","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2015.04.005","article-title":"Mammalian target of rapamycin and tuberous sclerosis complex","volume":"79","author":"Wataya-Kaneda","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2022.109153_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211031100","article-title":"Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine","volume":"14","author":"Schubert-Bast","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"20","key":"10.1016\/j.clim.2022.109153_bb0140","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/onc.2010.630","article-title":"The long and winding road to rational treatment of cancer associated with LKB1\/AMPK\/TSC\/mTORC1 signaling","volume":"30","author":"van Veelen","year":"2011","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2022.109153_bb0150","doi-asserted-by":"crossref","first-page":"8730816","DOI":"10.1155\/2019\/8730816","article-title":"LKB1\/AMPK pathway and drug response in cancer: a therapeutic perspective","volume":"2019","author":"Ciccarese","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.clim.2022.109153_bb0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.clim.2022.109153_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.751892","article-title":"The TSC complex-mTORC1 axis: from lysosomes to stress granules and back","volume":"9","author":"Rehbein","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.clim.2022.109153_bb0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/1744666X.2021.1964957","article-title":"Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"17","author":"Iwata","year":"2021","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12463","article-title":"Review: mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy","volume":"44","author":"Marsan","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbamcr.2018.06.011","article-title":"mTORC1 pathway in DNA damage response","volume":"1865","author":"Ma","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.clim.2022.109153_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111379","article-title":"Sestrin family - the stem controlling healthy ageing","volume":"192","author":"Haidurov","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0190","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/art.40223","article-title":"Review: metabolic control of immune system activation in rheumatic diseases","volume":"69","author":"Perl","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104241","article-title":"Microbiota-mediated skewing of tryptophan catabolism modulates CD4(+) T cells in lupus-prone mice","volume":"25","author":"Brown","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.12756","article-title":"mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging","volume":"1346","author":"Perl","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2022.109153_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","article-title":"Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship","volume":"72","author":"Jhanwar-Uniyal","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.clim.2022.109153_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/112_2013_17","article-title":"The role of mTORC1 in regulating protein synthesis and skeletal muscle mass in response to various mechanical stimuli","volume":"166","author":"Goodman","year":"2014","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13238-017-0409-3","article-title":"mTORC1 signaling in hepatic lipid metabolism","volume":"9","author":"Han","year":"2018","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0225","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.clim.2022.109153_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041199","article-title":"Distinct roles of mTOR targets S6K1 and S6K2 in breast cancer","volume":"21","author":"Sridharan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0235","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","article-title":"4E-BP1, a multifactor regulated multifunctional protein","volume":"15","author":"Qin","year":"2016","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0245","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/med.21675","article-title":"Skp2 in the ubiquitin-proteasome system: a comprehensive review","volume":"40","author":"Asmamaw","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.clim.2022.109153_bb0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-nutr-071714-034355","article-title":"The roles of mTOR complexes in lipid metabolism","volume":"35","author":"Caron","year":"2015","journal-title":"Annu. Rev. Nutr."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.clim.2022.109153_bb0260","first-page":"153","article-title":"Oncogenic roles of the PI3K\/AKT\/mTOR Axis","volume":"407","author":"Aoki","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","article-title":"The role of hypoxia-inducible factors in metabolic diseases","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0270","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1042\/BCJ20160822","article-title":"Amino acid homeostasis and signalling in mammalian cells and organisms","volume":"474","author":"Broer","year":"2017","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010261","article-title":"Regulation of skeletal muscle function by amino acids","volume":"12","author":"Kamei","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.clim.2022.109153_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103606","article-title":"The role of autophagy for the regeneration of the aging liver","volume":"21","author":"Xu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clim.2022.109153_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13431","article-title":"mTORC2: the other mTOR in autophagy regulation","volume":"20","author":"Ballesteros-Alvarez","year":"2021","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0290","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000490106","article-title":"Targeting SHP-1, 2 and SHIP pathways: a novel strategy for cancer treatment?","volume":"95","author":"Dempke","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.clim.2022.109153_bb0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sbi.2019.02.004","article-title":"AKTivation mechanisms","volume":"59","author":"Cole","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"585","key":"10.1016\/j.clim.2022.109153_bb0300","article-title":"Amplifying mTORC2 signals through AMPK during energetic stress","volume":"12","author":"E J","year":"2019","journal-title":"Sci. Signal."},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/genes11091045","article-title":"Regulation of mTORC2 signaling","volume":"11","author":"Fu","year":"2020","journal-title":"Genes (Basel)"},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garc\u00eda-Mart\u00ednez Juan","year":"2008","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.clim.2022.109153_bb0315","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.molmet.2016.06.007","article-title":"mTORC2 and AMPK differentially regulate muscle triglyceride content via Perilipin 3","volume":"5","author":"Kleinert","year":"2016","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.clim.2022.109153_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/molpharm.121.000310","article-title":"mTOR regulation of AGC kinases: new twist to an old tail","volume":"101","author":"Baffi","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0325","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tibs.2022.03.003","article-title":"Protein kinase C: release from quarantine by mTORC2","volume":"47","author":"Baffi","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.clim.2022.109153_bb0330","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biopha.2015.02.017","article-title":"Update on the role of autophagy in systemic lupus erythematosus: a novel therapeutic target","volume":"71","author":"Pan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.clim.2022.109153_bb0335","series-title":"Autophagy: Biology and Diseases","first-page":"67","article-title":"Regulation of autophagy by mTOR signaling pathway","author":"Wang","year":"2019"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14305","article-title":"Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways","volume":"1467","author":"Al-Bari","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni.3365","article-title":"Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis","volume":"17","author":"Wei","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0355","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41577-018-0095-2","article-title":"Autophagy in the renewal, differentiation and homeostasis of immune cells","volume":"19","author":"Clarke","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.clim.2022.109153_bb0360","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00441-17","article-title":"MTORC1 regulates both general autophagy and Mitophagy induction after oxidative phosphorylation uncoupling","volume":"37","author":"Bartolome","year":"2017","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.clim.2022.109153_bb0365","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.celrep.2016.09.054","article-title":"Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex","volume":"17","author":"Ebrahimi-Fakhari","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0370","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/hmg\/ddr529","article-title":"Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition","volume":"21","author":"Gilkerson","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0375","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"10126","key":"10.1016\/j.clim.2022.109153_bb0380","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.12845","article-title":"mTOR signaling at the crossroads of environmental signals and T-cell fate decisions","volume":"295","author":"Huang","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.clim.2022.109153_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165845","article-title":"Mitochondrial function in immune cells in health and disease","volume":"1866","author":"Faas","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.clim.2022.109153_bb0395","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0400","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0405","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0410","article-title":"Function and role of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2022.109153_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-016-0616-6","article-title":"Regulatory T cells in SLE: biology and use in treatment","volume":"18","author":"Giang","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clim.2022.109153_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0425","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clim.2022.109153_bb0430","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0435","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3389\/fimmu.2018.00786","article-title":"Targeting regulatory T cells to treat patients with systemic lupus erythematosus","volume":"9","author":"Mizui","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104160","article-title":"Regulatory T cells: master thieves of the immune system","volume":"355","author":"Akkaya","year":"2020","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0445","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2019.04.005","article-title":"Regulatory immune mechanisms beyond regulatory T cells","volume":"40","author":"Christoffersson","year":"2019","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0450","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humimm.2017.12.013","article-title":"Regulatory T cells for tolerance","volume":"79","author":"Kawai","year":"2018","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0455","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1002\/jcp.27553","article-title":"Contribution of regulatory T cells to cancer: a review","volume":"234","author":"Najafi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.2019-0003-OA","article-title":"Regulatory T cells: pathophysiological roles and clinical applications","volume":"69","author":"Sakai","year":"2020","journal-title":"Keio. J. Med."},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0465","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/1744666X.2019.1620602","article-title":"Regulatory T cells: the future of autoimmune disease treatment","volume":"15","author":"Ryba-Stanislawowska","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0470","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/dxab045","article-title":"The adaptability of regulatory T cells and Foxp3","volume":"33","author":"Hori","year":"2021","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0475","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imm.13064","article-title":"Regulation of regulatory T cells in cancer","volume":"157","author":"Stockis","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2022.109153_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104251","article-title":"Role of orally induced regulatory T cells in immunotherapy and tolerance","volume":"359","author":"Bertolini","year":"2021","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0485","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0490","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13190","article-title":"Regulatory T-cells in helminth infection: induction, function and therapeutic potential","volume":"160","author":"White","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2022.109153_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102461","article-title":"The progress and prospect of regulatory T cells in autoimmune diseases","volume":"111","author":"Zhang","year":"2020","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0500","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0505","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0510","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2362.2007.01882.x","article-title":"The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"37","author":"Lin","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.clim.2022.109153_bb0515","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2005.049924","article-title":"Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids","volume":"65","author":"Suarez","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2022.109153_bb0520","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/ard.2009.117135","article-title":"Treg and lupus","volume":"69","author":"Bonelli","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0525","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-018-0714-8","article-title":"Tregs in SLE: an update","volume":"20","author":"La Cava","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.clim.2022.109153_bb0530","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.clim.2022.109153_bb0535","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.887489","article-title":"Genetic variations controlling regulatory T cell development and activity in mouse models of lupus-like autoimmunity","volume":"13","author":"Roach","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155654","article-title":"Role of IL-6 in the commitment of T cell subsets","volume":"146","author":"Korn","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020188","article-title":"Cellular metabolic regulation in the differentiation and function of regulatory T cells","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.clim.2022.109153_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-dose IL-2 therapy in autoimmune and rheumatic diseases","volume":"12","author":"Grasshoff","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0560","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2019.00051","article-title":"Immunomodulatory effects of flavonoids: possible induction of T CD4+ regulatory cells through suppression of mTOR pathway signaling activity","volume":"10","author":"Hosseinzade","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0565","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2018.00069","article-title":"Immunometabolism and PI(3)K signaling as a link between IL-2, Foxp3 expression, and suppressor function in regulatory T cells","volume":"9","author":"Fan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0570","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coi.2017.04.005","article-title":"mTOR signaling in the differentiation and function of regulatory and effector T cells","volume":"46","author":"Zeng","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0575","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2017.07.012","article-title":"The serine\/threonine protein phosphatase 2A controls autoimmunity","volume":"186","author":"Sharabi","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0580","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biocel.2017.10.008","article-title":"Therapeutic targeting of PP2A","volume":"96","author":"O\u2019Connor","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.clim.2022.109153_bb0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2017.04.004","article-title":"The role of AMPK in T cell metabolism and function","volume":"46","author":"Ma","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899975","article-title":"mTORC1 inhibition protects human regulatory T cells from granzyme-B-induced apoptosis","volume":"13","author":"Eskandari","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2022.109153_bb0595","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2022.03.004","article-title":"Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis","volume":"245","author":"Caza","year":"2022","journal-title":"Transl. Res."},{"issue":"7459","key":"10.1016\/j.clim.2022.109153_bb0600","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.clim.2022.109153_bb0605","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4161\/15384101.2014.991572","article-title":"mTOR coordinates protein synthesis, mitochondrial activity and proliferation","volume":"14","author":"Morita","year":"2015","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0615","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2022.109153_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633845","article-title":"Oxidative stress in SLE T cells, is NRF2 really the target to treat?","volume":"12","author":"Ohl","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0625","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"issue":"31","key":"10.1016\/j.clim.2022.109153_bb0630","doi-asserted-by":"crossref","first-page":"12526","DOI":"10.1073\/pnas.1302455110","article-title":"Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology","volume":"110","author":"Betz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0635","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/14728222.2020.1832464","article-title":"Systemic lupus erythematosus (SLE): emerging therapeutic targets","volume":"24","author":"Mathias","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0640","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.09.022","article-title":"Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway","volume":"50","author":"He","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0645","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.clim.2022.109153_bb0650","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of Treg cell differentiation and function by the Interleukin-21-mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0655","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.18632\/aging.100925","article-title":"Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.clim.2022.109153_bb0660","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","article-title":"Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus","volume":"191","author":"Lai","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020723","article-title":"Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases","volume":"22","author":"Wojcik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2022.109153_bb0670","first-page":"10(6)","article-title":"N-Acetylcysteine (NAC): impacts on Human Health","author":"Tenorio","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.clim.2022.109153_bb0675","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/BOR.0000000000000687","article-title":"Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases","volume":"32","author":"Wyman","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.clim.2022.109153_bb0680","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0685","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J. Intern. Med."},{"issue":"4","key":"10.1016\/j.clim.2022.109153_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0695","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12882-018-0847-z","article-title":"Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review","volume":"19","author":"Margiotta","year":"2018","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0700","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update omicronn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0705","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"28;1(1)","key":"10.1016\/j.clim.2022.109153_bb0710","first-page":"5","article-title":"Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation","volume":"Feb","author":"Yan","year":"2015","journal-title":"J. Rheum. Dis. Treat."},{"issue":"274","key":"10.1016\/j.clim.2022.109153_bb0715","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2022.109153_bb0720","doi-asserted-by":"crossref","first-page":"3406032","DOI":"10.1155\/2020\/3406032","article-title":"The regulatory effects of mTOR complexes in the differentiation and function of CD4(+) T cell subsets","volume":"2020","author":"Wang","year":"2020","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.clim.2022.109153_bb0725","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5483\/BMBRep.2019.52.1.299","article-title":"Growth signaling and longevity in mouse models","volume":"52","author":"Kim","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.clim.2022.109153_bb0730","first-page":"686","article-title":"mTOR links environmental signals to T cell fate decisions","volume":"5","author":"Chapman","year":"2014","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2022.109153_bb0735","article-title":"PPARgamma-induced upregulation of subcutaneous fat adiponectin secretion, glyceroneogenesis and BCAA oxidation requires mTORC1 activity","volume":"1866","author":"Andrade","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"12","key":"10.1016\/j.clim.2022.109153_bb0740","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101054RR","article-title":"Raptor is critical for increasing the mitochondrial proteome and skeletal muscle force during hypertrophy","volume":"35","author":"Baraldo","year":"2021","journal-title":"FASEB J."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:12:31Z","timestamp":1761495151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":148,"alternative-id":["S1521661622002340"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109153","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109153"}}